iC9-GD2-CAR-VZV-CTLs

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iC9-GD2-CAR-VZV-CTLs, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma [Phase 1]